These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 24214532)
41. Inhibition of Influenza A Virus by Human Infant Saliva. Gilbertson B; Edenborough K; McVernon J; Brown LE Viruses; 2019 Aug; 11(8):. PubMed ID: 31434247 [TBL] [Abstract][Full Text] [Related]
42. Protein-bound sialic acid in saliva contributes directly to salivary anti-influenza virus activity. Kobayashi K; Shono C; Mori T; Kitazawa H; Ota N; Kurebayashi Y; Suzuki T Sci Rep; 2022 Apr; 12(1):6636. PubMed ID: 35459785 [TBL] [Abstract][Full Text] [Related]
43. Sialic acid tissue distribution and influenza virus tropism. Kumlin U; Olofsson S; Dimock K; Arnberg N Influenza Other Respir Viruses; 2008 Sep; 2(5):147-54. PubMed ID: 19453419 [TBL] [Abstract][Full Text] [Related]
44. Evidence of a soluble substrate for the receptor-destroying enzyme of influenza C virus. O'Callaghan RJ; Labat DD Infect Immun; 1983 Jan; 39(1):305-10. PubMed ID: 6822417 [TBL] [Abstract][Full Text] [Related]
45. Leptotrichia buccalis hemagglutination in cell binding and salivary inhibition studies. Falkler WA; Hawley CE; Mongiello JR J Periodontal Res; 1978 Sep; 13(5):425-32. PubMed ID: 151130 [TBL] [Abstract][Full Text] [Related]
46. [Capacity of human saliva to neutralize influenza virus hemagglutinins]. KOSIAKOV PN; SHCHAVELEVA AP Vopr Virusol; 1956; 1(3):35-40. PubMed ID: 13361186 [No Abstract] [Full Text] [Related]
47. Antiviral activities in human saliva. Malamud D; Abrams WR; Barber CA; Weissman D; Rehtanz M; Golub E Adv Dent Res; 2011 Apr; 23(1):34-7. PubMed ID: 21441478 [TBL] [Abstract][Full Text] [Related]
48. [Action of saliva on the viability of influenza virus]. GAILONSKAIA IN Vopr Virusol; 1958; 3(3):174-5. PubMed ID: 13570000 [No Abstract] [Full Text] [Related]
49. Effect of polyphloroglucinolphosphate on influenza virus and on chicken red cells. PENTTINEN K Ann Med Exp Biol Fenn; 1956; 34(1):88-94. PubMed ID: 13373093 [No Abstract] [Full Text] [Related]
50. [Effect of human saliva on adsorptive capacity of influenza virus]. GAILONSKAIA IN Vopr Virusol; 1957; 2(1):22-5. PubMed ID: 13423200 [No Abstract] [Full Text] [Related]
51. Studies on several inhibitors against influenza viruses. I. Production and purification of receptor destroying enzyme (RDE). KAWAMURA K Tohoku J Exp Med; 1958 Apr; 67(4):372. PubMed ID: 13581055 [No Abstract] [Full Text] [Related]
52. Serological comparison of hemagglutinating encephalomyelitis viruses isolated from different outbreaks. Greig AS; Girard A Can J Comp Med; 1969 Jan; 33(1):25-8. PubMed ID: 4237291 [TBL] [Abstract][Full Text] [Related]
54. Corrigendum: The molecular basis of differential host responses to avian influenza viruses in avian species with differing susceptibility. Morris KM; Mishra A; Raut AA; Gaunt ER; Borowska D; Kuo RI; Wang B; Vijayakumar P; Chingtham S; Dutta R; Baillie K; Digard P; Vervelde L; Burt DW; Smith J Front Cell Infect Microbiol; 2023; 13():1194878. PubMed ID: 37082716 [TBL] [Abstract][Full Text] [Related]
55. Studies on antiviral immunity using tissue culture methods. I. The susceptibility and resistance of lung tissue explants to influenza virus in previously immunised animals. SOLOVYOV VD; ALEKSEYEVA AK Acta Virol; 1960 May; 4():129-36. PubMed ID: 13854897 [No Abstract] [Full Text] [Related]
57. In vivo activity of an inhibitor of influenza virus-induced ribonucleic acid polymerase. Ho PP; Walters CP; Streightoff F; Baker LA; DeLong DC Antimicrob Agents Chemother (Bethesda); 1967; 7():636-41. PubMed ID: 4300242 [No Abstract] [Full Text] [Related]
58. An α2,3-Linked Sialylglycopolymer as a Multivalent Glycoligand Against Avian and Human Influenza Viruses. Tanaka T; Zhou Y; Tamoto C; Kurebayashi Y; Takahashi T; Suzuki T J Appl Glycosci (1999); 2017; 64(2):43-48. PubMed ID: 34354496 [TBL] [Abstract][Full Text] [Related]
59. [Viral inhibitors in the saliva of normal subjects and influenza patients]. Kosiakov PN; Vasilenko VA Vopr Virusol; 1965; 10(2):204-9. PubMed ID: 5855769 [No Abstract] [Full Text] [Related]